Uncategorized

Uncategorized

New Releases from NCBI BookshelfBuilding multi-professional UK partnerships and networks to improve access to palliative care for people experiencing homelessness [Internet].​Building multi-professional UK partnerships and networks to improve access to palliative care for people experiencing homelessness [Internet].

People experiencing homelessness have high rates of multi-morbidity and age-related conditions at a young age. Despite having high support needs, […]

Uncategorized

New Releases from NCBI BookshelfPembrolizumab (Keytruda): Indication: For the adjuvant treatment of adult patients with stage IB (T2a ≥ 4 cm), II, or IIIA non-small cell lung cancer who have undergone complete resection and platinum-based chemotherapy: Reimbursement Recommendation [Internet].​Pembrolizumab (Keytruda): Indication: For the adjuvant treatment of adult patients with stage IB (T2a ≥ 4 cm), II, or IIIA non-small cell lung cancer who have undergone complete resection and platinum-based chemotherapy: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Keytruda be reimbursed by public drug plans for the adjuvant treatment of adult patients

Uncategorized

New Releases from NCBI BookshelfPembrolizumab (Keytruda): Indication: For the treatment of adult and pediatric patients with unresectable or metastatic microsatellite instability-high or mismatch repair deficient solid tumours, as determined by a validated test, that have progressed following prior treatment and who have no satisfactory alternative treatment options: Reimbursement Recommendation [Internet].​Pembrolizumab (Keytruda): Indication: For the treatment of adult and pediatric patients with unresectable or metastatic microsatellite instability-high or mismatch repair deficient solid tumours, as determined by a validated test, that have progressed following prior treatment and who have no satisfactory alternative treatment options: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Keytruda be reimbursed by public drug plans for the treatment of adult and pediatric

Uncategorized

New Releases from NCBI BookshelfCannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT [Internet].​Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT [Internet].

There are no licensed pharmacological treatments for people who are at clinical high risk of developing psychosis. Although psychological interventions

Uncategorized

New Releases from NCBI BookshelfViews of healthcare workers on development of support for people with post-COVID syndrome in Kyrgyzstan: a survey study [Internet].​Views of healthcare workers on development of support for people with post-COVID syndrome in Kyrgyzstan: a survey study [Internet].

After the acute period from severe-acute-respiratory-syndrome-related coronavirus infection, many coronavirus infection survivors continue to have ongoing symptoms, but little is

Scroll to Top